Indian pharmaceutical companies received a third of the warnings the United States Food and Drug Administration (FDA) issued for misbranding, selling unapproved medicines and violating Current Good Management Practices (CGMP)
A Shaping Of Pharmaceutical Industry To The Emerging Markets Of The World
As the competitive market has evolved all over world, manufacturers in all industries have been presented with a fundamental challenge with new techniques so they can adjust to a new
Can Jammu & Kashmir build on its pharma base?
Jammu & Kashmir may not be a big market for the Indian pharmaceutical industry, it has a lot to offer to the sector. Industry estimates pharma market size of around
India seeks “clear roadmap” from China to ramp up export of pharma products
In an unusual move, India on Friday used a hugely popular Chinese movie to seek enhanced market access for Indian medicines in China as the drug regulators of both countries
The National Institute for Health and Care Excellence (NICE) and Public Health England (PHE) have issued draft antimicrobial prescribing guidance on impetigo.
The condition is normally treated with an antibiotic to help reduce the spread of infection and speed up recovery, but the two organisations have now found that a topical antiseptic such
The Health Service Executive (HSE) has granted reimbursement for Pierre Fabre’s Braftovi (encorafenib) and Mektovi (binimetinib) combination in Ireland.
The treatment has been accepted for use on the Irish health service to treat adult patients with unresectable or metastatic melanoma with a mutation in the BRAF V600 gene. The